Cargando…

RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE

Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Rivka C., Du, Peicheng, Feng, Di, Dhawan, Kopal, Rönnblom, Lars, Eloranta, Maija-Leena, Donnelly, Robert, Barnes, Betsy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548774/
https://www.ncbi.nlm.nih.gov/pubmed/23349905
http://dx.doi.org/10.1371/journal.pone.0054487
_version_ 1782256367833186304
author Stone, Rivka C.
Du, Peicheng
Feng, Di
Dhawan, Kopal
Rönnblom, Lars
Eloranta, Maija-Leena
Donnelly, Robert
Barnes, Betsy J.
author_facet Stone, Rivka C.
Du, Peicheng
Feng, Di
Dhawan, Kopal
Rönnblom, Lars
Eloranta, Maija-Leena
Donnelly, Robert
Barnes, Betsy J.
author_sort Stone, Rivka C.
collection PubMed
description Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-SLE risk haplotypes. IRF5 alternative splicing has also been shown to be elevated in SLE patients. Given that human IRF5 exists as multiple alternatively spliced transcripts with distinct function(s), it is important to determine whether the IRF5 transcript profile expressed in healthy donor immune cells is different from that expressed in SLE patients. Moreover, it is not currently known whether an IRF5-SLE risk haplotype defines the profile of IRF5 transcripts expressed. Using standard molecular cloning techniques, we identified and isolated 14 new differentially spliced IRF5 transcript variants from purified monocytes of healthy donors and SLE patients to generate an IRF5 variant transcriptome. Next-generation sequencing was then used to perform in-depth and quantitative analysis of full-length IRF5 transcript expression in primary immune cells of SLE patients and healthy donors by next-generation sequencing. Evidence for additional alternatively spliced transcripts was obtained from de novo junction discovery. Data from these studies support the overall complexity of IRF5 alternative splicing in SLE. Results from next-generation sequencing correlated with cloning and gave similar abundance rankings in SLE patients thus supporting the use of this new technology for in-depth single gene transcript profiling. Results from this study provide the first proof that 1) SLE patients express an IRF5 transcript signature that is distinct from healthy donors, 2) an IRF5-SLE risk haplotype defines the top four most abundant IRF5 transcripts expressed in SLE patients, and 3) an IRF5 transcript signature enables clustering of SLE patients with the H2 risk haplotype.
format Online
Article
Text
id pubmed-3548774
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35487742013-01-24 RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE Stone, Rivka C. Du, Peicheng Feng, Di Dhawan, Kopal Rönnblom, Lars Eloranta, Maija-Leena Donnelly, Robert Barnes, Betsy J. PLoS One Research Article Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-SLE risk haplotypes. IRF5 alternative splicing has also been shown to be elevated in SLE patients. Given that human IRF5 exists as multiple alternatively spliced transcripts with distinct function(s), it is important to determine whether the IRF5 transcript profile expressed in healthy donor immune cells is different from that expressed in SLE patients. Moreover, it is not currently known whether an IRF5-SLE risk haplotype defines the profile of IRF5 transcripts expressed. Using standard molecular cloning techniques, we identified and isolated 14 new differentially spliced IRF5 transcript variants from purified monocytes of healthy donors and SLE patients to generate an IRF5 variant transcriptome. Next-generation sequencing was then used to perform in-depth and quantitative analysis of full-length IRF5 transcript expression in primary immune cells of SLE patients and healthy donors by next-generation sequencing. Evidence for additional alternatively spliced transcripts was obtained from de novo junction discovery. Data from these studies support the overall complexity of IRF5 alternative splicing in SLE. Results from next-generation sequencing correlated with cloning and gave similar abundance rankings in SLE patients thus supporting the use of this new technology for in-depth single gene transcript profiling. Results from this study provide the first proof that 1) SLE patients express an IRF5 transcript signature that is distinct from healthy donors, 2) an IRF5-SLE risk haplotype defines the top four most abundant IRF5 transcripts expressed in SLE patients, and 3) an IRF5 transcript signature enables clustering of SLE patients with the H2 risk haplotype. Public Library of Science 2013-01-18 /pmc/articles/PMC3548774/ /pubmed/23349905 http://dx.doi.org/10.1371/journal.pone.0054487 Text en © 2013 Stone et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Stone, Rivka C.
Du, Peicheng
Feng, Di
Dhawan, Kopal
Rönnblom, Lars
Eloranta, Maija-Leena
Donnelly, Robert
Barnes, Betsy J.
RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE
title RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE
title_full RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE
title_fullStr RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE
title_full_unstemmed RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE
title_short RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE
title_sort rna-seq for enrichment and analysis of irf5 transcript expression in sle
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548774/
https://www.ncbi.nlm.nih.gov/pubmed/23349905
http://dx.doi.org/10.1371/journal.pone.0054487
work_keys_str_mv AT stonerivkac rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle
AT dupeicheng rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle
AT fengdi rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle
AT dhawankopal rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle
AT ronnblomlars rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle
AT elorantamaijaleena rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle
AT donnellyrobert rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle
AT barnesbetsyj rnaseqforenrichmentandanalysisofirf5transcriptexpressioninsle